The Medicare GLP-1 Bridge is a short-term demonstration run by the Centers for Medicare & Medicaid Services (CMS) that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027
Wharam JF et al
The evidence presented here is meant to inform that decision, not make it for you
With the Wegovy pen, some people may later increase beyond the 2.4 mg maintenance dose , up to a maximum of 7.2 mg once weekly , if they've tolerated 2.4 mg for at least four weeks and their provider recommends it for further weight loss
However, some sports medicine research suggests that taking it alongside a small amount of complex carbohydrates may stimulate a mild insulin release, which has been shown to further drive carnitine uptake directly into the skeletal muscle tissues, enhancing its recovery benefits